Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has ...

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...

The deal will help the ATE solution supplier scale its pre-silicon validation and automated pattern generation technologies.

LED candles are neat, but they’re very suboptimal for wish-making: you can’t blow them out. Unless you take the circuit from ...

Aliasing is thankfully becoming a less frequent problem due to improved instrument designs. Users should still be aware of it ...

The rapidly-improving speed and versatility of digital computers has mostly driven analogue computers out of use in modern systems, as has the relative difficulty of programming an analogue computer.